Skip to main content
Top
Published in: Aesthetic Plastic Surgery 1/2022

01-02-2022 | Botulinum Toxin | Review

A Systematic Review And Meta-Analysis: Botulinum Toxin A Effect on Postoperative Facial Scar Prevention

Authors: Shuai Yue, Mengran Ju, Zhe Su

Published in: Aesthetic Plastic Surgery | Issue 1/2022

Login to get access

Abstract

Background

Postoperative facial scarring can be a significant psychological burden for patients to carry after surgery, often resulting in prolonged mental health dysfunction. Currently, there is no established method to prevent facial scar formation; however, there are several methods to prevent facial scar hyperplasia and improve scar quality. Botulinum toxin A (BTA) has been widely used due to its properties of muscle paralysis and known success in plastic surgery and cosmetology. This meta-analysis aimed to evaluate the efficacy of BTA in preventing postoperative facial scar hyperplasia and improving scar quality.

Methods

PubMed, MEDLINE, EMBASE, web of science, and Cochrane libraries were searched for randomized controlled trials (RCTs) (published before May 2021) wherein BTA was used for the treatment of facial scars. The efficacy and safety of BTA were evaluated by the following scales: the Vancouver Scar Scale (VSS), Visual Analog Scale (VAS), Observer Scar Assessment Scale (OSAS), Patient Scar Assessment Scale (PSAS), and Stony Brook Scar Evaluation Scale (SBSES); the BTA effect on scar width and complications was also assessed.

Results

Ten RCTs involving 114 cases were included. Through quantitative analysis, the BTA injection group had a higher VAS score, lower VSS score, lower OSAS score, and smaller scar width. However, no significant difference was noted in the incidence of postoperative complications between the two groups.

Conclusions

This meta-analysis demonstrated that BTA can safely improve the appearance of postoperative facial scars by significantly inhibiting scar hyperplasia and improving scar quality.

Level of Evidence III

This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.​springer.​com/​00266.
Literature
1.
go back to reference Kim SH, Lee SJ, Lee JW, Jeong HS, Suh IS (2019) Clinical trial to evaluate the efficacy of botulinum toxin type A injection for reducing scars in patients with forehead laceration: a double-blinded, randomized controlled study. Med (Baltimore) 98(34):e16952 Kim SH, Lee SJ, Lee JW, Jeong HS, Suh IS (2019) Clinical trial to evaluate the efficacy of botulinum toxin type A injection for reducing scars in patients with forehead laceration: a double-blinded, randomized controlled study. Med (Baltimore) 98(34):e16952
2.
go back to reference Tebble NJ, Thomas DW, Price P (2004) Anxiety and self-consciousness in patients with minor facial lacerations. J Adv Nurs 47(4):417–426PubMed Tebble NJ, Thomas DW, Price P (2004) Anxiety and self-consciousness in patients with minor facial lacerations. J Adv Nurs 47(4):417–426PubMed
3.
go back to reference Jeong HS et al (2015) Effect of botulinum toxin type A on differentiation of fibroblasts derived from scar tissue. Plast Reconstr Surg 136(2):171e–178ePubMed Jeong HS et al (2015) Effect of botulinum toxin type A on differentiation of fibroblasts derived from scar tissue. Plast Reconstr Surg 136(2):171e–178ePubMed
4.
go back to reference Sherris DA, Larrabee WF Jr, Murakami CS (1995) Management of scar contractures, hypertrophic scars, and keloids. Otolaryngol Clin North Am 28(5):1057–1068PubMed Sherris DA, Larrabee WF Jr, Murakami CS (1995) Management of scar contractures, hypertrophic scars, and keloids. Otolaryngol Clin North Am 28(5):1057–1068PubMed
6.
go back to reference Xiao Z, Zhang F, Cui Z (2009) Treatment of hypertrophic scars with intralesional botulinum toxin type A injections: a preliminary report. Aesthetic Plast Surg 33(3):409–412PubMed Xiao Z, Zhang F, Cui Z (2009) Treatment of hypertrophic scars with intralesional botulinum toxin type A injections: a preliminary report. Aesthetic Plast Surg 33(3):409–412PubMed
7.
go back to reference Xiao Z, Zhang F, Lin W, Zhang M, Liu Y (2010) Effect of botulinum toxin type A on transforming growth factor beta1 in fibroblasts derived from hypertrophic scar: a preliminary report. Aesthetic Plast Surg 34(4):424–427PubMed Xiao Z, Zhang F, Lin W, Zhang M, Liu Y (2010) Effect of botulinum toxin type A on transforming growth factor beta1 in fibroblasts derived from hypertrophic scar: a preliminary report. Aesthetic Plast Surg 34(4):424–427PubMed
8.
go back to reference Ibrahim O, Keller EC, Arndt KA (2014) Update on botulinum neurotoxin use in aesthetic dermatology. Semin Cutan Med Surg 33(4):152–156PubMed Ibrahim O, Keller EC, Arndt KA (2014) Update on botulinum neurotoxin use in aesthetic dermatology. Semin Cutan Med Surg 33(4):152–156PubMed
9.
go back to reference Scott AB, Rosenbaum A, Collins CC (1973) Pharmacologic weakening of extraocular muscles. Invest Ophthalmol 12(12):924–927PubMed Scott AB, Rosenbaum A, Collins CC (1973) Pharmacologic weakening of extraocular muscles. Invest Ophthalmol 12(12):924–927PubMed
10.
go back to reference Cocco A, Albanese A (2018) Recent developments in clinical trials of botulinum neurotoxins. Toxicon 147(1):77–83PubMed Cocco A, Albanese A (2018) Recent developments in clinical trials of botulinum neurotoxins. Toxicon 147(1):77–83PubMed
11.
go back to reference Sherris DA, Gassner HG (2002) Botulinum toxin to minimize facial scarring. Facial Plast Surg 18(1):35–39PubMed Sherris DA, Gassner HG (2002) Botulinum toxin to minimize facial scarring. Facial Plast Surg 18(1):35–39PubMed
12.
go back to reference Lu L et al (2005) The temporal effects of anti-TGF-β1, 2, and 3 monoclonal antibody on wound healing and hypertrophic scar formation. J Am Coll Surg 201(3):391–397PubMed Lu L et al (2005) The temporal effects of anti-TGF-β1, 2, and 3 monoclonal antibody on wound healing and hypertrophic scar formation. J Am Coll Surg 201(3):391–397PubMed
13.
go back to reference Reid RR, Roy N, Mogford JE, Zimmerman H, Lee C, Mustoe TA (2007) Reduction of hypertrophic scar via retroviral delivery of a dominant negative TGF-beta receptor II. J Plast Reconstr Aesthet Surg 60(1):64–72PubMed Reid RR, Roy N, Mogford JE, Zimmerman H, Lee C, Mustoe TA (2007) Reduction of hypertrophic scar via retroviral delivery of a dominant negative TGF-beta receptor II. J Plast Reconstr Aesthet Surg 60(1):64–72PubMed
14.
go back to reference Gassner HG, Sherris DA, Otley CC (2000) Treatment of facial wounds with botulinum toxin A improves cosmetic outcome in primates. Plast Reconstr Surg 105(6):1948–1953PubMed Gassner HG, Sherris DA, Otley CC (2000) Treatment of facial wounds with botulinum toxin A improves cosmetic outcome in primates. Plast Reconstr Surg 105(6):1948–1953PubMed
15.
go back to reference Li YH et al (2018) A randomized, placebo-controlled, double-blind, prospective clinical trial of botulinum toxin type A in prevention of hypertrophic scar development in median sternotomy wound. Aesthetic Plast Surg 42(5):1364–1369PubMed Li YH et al (2018) A randomized, placebo-controlled, double-blind, prospective clinical trial of botulinum toxin type A in prevention of hypertrophic scar development in median sternotomy wound. Aesthetic Plast Surg 42(5):1364–1369PubMed
16.
go back to reference Abedini R, Mehdizade Rayeni N, Haddady Abianeh S, Rahmati J, Teymourpour A, Nasimi M (2020) Botulinum toxin type A injection for mammoplasty and abdominoplasty scar management: A split-scar double-blinded randomized controlled study. Aesthetic Plast Surg 44(6):2270–2276PubMed Abedini R, Mehdizade Rayeni N, Haddady Abianeh S, Rahmati J, Teymourpour A, Nasimi M (2020) Botulinum toxin type A injection for mammoplasty and abdominoplasty scar management: A split-scar double-blinded randomized controlled study. Aesthetic Plast Surg 44(6):2270–2276PubMed
17.
go back to reference Elshahed AR, Elmanzalawy KS, Shehata H, ElSaie ML (2020) Effect of botulinum toxin type A for treating hypertrophic scars: a split-scar, double-blind randomized controlled trial. J Cosmet Dermatol 19(9):2252–2258PubMed Elshahed AR, Elmanzalawy KS, Shehata H, ElSaie ML (2020) Effect of botulinum toxin type A for treating hypertrophic scars: a split-scar, double-blind randomized controlled trial. J Cosmet Dermatol 19(9):2252–2258PubMed
18.
go back to reference Moher D et al (2015) Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev 4(1):1PubMedPubMedCentral Moher D et al (2015) Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev 4(1):1PubMedPubMedCentral
19.
go back to reference Chang CS, Wallace CG, Hsiao YC, Chang CJ, Chen PK (2014) Botulinum toxin to improve results in cleft lip repair. Plast Reconstr Surg 134(3):511–516PubMed Chang CS, Wallace CG, Hsiao YC, Chang CJ, Chen PK (2014) Botulinum toxin to improve results in cleft lip repair. Plast Reconstr Surg 134(3):511–516PubMed
20.
go back to reference Chang CS, Wallace CG, Hsiao YC, Chang CJ, Chen PK (2014) Botulinum toxin to improve results in cleft lip repair: a double-blinded, randomized, vehicle-controlled clinical trial. PLoS ONE 9(12):e115690PubMedPubMedCentral Chang CS, Wallace CG, Hsiao YC, Chang CJ, Chen PK (2014) Botulinum toxin to improve results in cleft lip repair: a double-blinded, randomized, vehicle-controlled clinical trial. PLoS ONE 9(12):e115690PubMedPubMedCentral
21.
go back to reference Gassner HG et al (2006) Botulinum toxin to improve facial wound healing: a prospective, blinded, placebo-controlled study. Mayo Clin Proc 81(8):1023–1028PubMed Gassner HG et al (2006) Botulinum toxin to improve facial wound healing: a prospective, blinded, placebo-controlled study. Mayo Clin Proc 81(8):1023–1028PubMed
22.
go back to reference Hu L et al (2018) Effects of botulinum toxin on improving facial surgical scars: a prospective, split-scar, double-blind, randomized controlled trial. Plast Reconstr Surg 141(3):646–650PubMed Hu L et al (2018) Effects of botulinum toxin on improving facial surgical scars: a prospective, split-scar, double-blind, randomized controlled trial. Plast Reconstr Surg 141(3):646–650PubMed
23.
go back to reference Huang RL, Ho CK, Tremp M, Xie Y, Li Q, Zan T (2019) Early postoperative application of botulinum toxin type a prevents hypertrophic scarring after epicanthoplasty: a split-face, double-blind, randomized trial. Plast Reconstr Surg 144(4):835–844PubMed Huang RL, Ho CK, Tremp M, Xie Y, Li Q, Zan T (2019) Early postoperative application of botulinum toxin type a prevents hypertrophic scarring after epicanthoplasty: a split-face, double-blind, randomized trial. Plast Reconstr Surg 144(4):835–844PubMed
24.
go back to reference Lee SH, Min HJ, Kim YW, Cheon YW (2018) The efficacy and safety of early postoperative botulinum toxin A injection for facial scars. Aesthetic Plast Surg 42(2):530–537PubMed Lee SH, Min HJ, Kim YW, Cheon YW (2018) The efficacy and safety of early postoperative botulinum toxin A injection for facial scars. Aesthetic Plast Surg 42(2):530–537PubMed
25.
go back to reference Navarro-Barquín DF et al (2019) Use of the type A botulinum toxin in patients submitted to cheiloplasty to improve results in scarring in patients with nonsyndromic cleft lip and palate. Eur J Plast Surg 42(3):291–294 Navarro-Barquín DF et al (2019) Use of the type A botulinum toxin in patients submitted to cheiloplasty to improve results in scarring in patients with nonsyndromic cleft lip and palate. Eur J Plast Surg 42(3):291–294
26.
go back to reference Zelken J et al (2016) Donor site aesthetic enhancement with preoperative botulinum toxin in forehead flap nasal reconstruction. Ann Plast Surg 77(5):535–538PubMed Zelken J et al (2016) Donor site aesthetic enhancement with preoperative botulinum toxin in forehead flap nasal reconstruction. Ann Plast Surg 77(5):535–538PubMed
27.
go back to reference Ziade M et al (2013) Use of botulinum toxin type A to improve treatment of facial wounds: a prospective randomised study. J Plast Reconstr Aesthet Surg 66(2):209–214PubMed Ziade M et al (2013) Use of botulinum toxin type A to improve treatment of facial wounds: a prospective randomised study. J Plast Reconstr Aesthet Surg 66(2):209–214PubMed
28.
go back to reference Sung YT, Wu JS (2018) The visual analogue scale for rating, ranking and paired-comparison (VAS-RRP): a new technique for psychological measurement. Behav Res Methods 50(4):1694–1715PubMedPubMedCentral Sung YT, Wu JS (2018) The visual analogue scale for rating, ranking and paired-comparison (VAS-RRP): a new technique for psychological measurement. Behav Res Methods 50(4):1694–1715PubMedPubMedCentral
29.
go back to reference Thompson CM, Sood RF, Honari S, Carrougher GJ, Gibran NS (2015) What score on the vancouver scar scale constitutes a hypertrophic scar? results from a survey of north American burn-care providers. Burns 41(7):1442–1448PubMedPubMedCentral Thompson CM, Sood RF, Honari S, Carrougher GJ, Gibran NS (2015) What score on the vancouver scar scale constitutes a hypertrophic scar? results from a survey of north American burn-care providers. Burns 41(7):1442–1448PubMedPubMedCentral
30.
go back to reference Refahee SM et al (2020) Is PRP effective in reducing the scar width of primary cleft lip repair? A randomized controlled clinical study. Cleft Palate Craniofac J 57(5):581–588PubMed Refahee SM et al (2020) Is PRP effective in reducing the scar width of primary cleft lip repair? A randomized controlled clinical study. Cleft Palate Craniofac J 57(5):581–588PubMed
31.
go back to reference Prodromidou A et al (2015) Botulinum toxin for the prevention and healing of wound scars: a systematic review of the literature. Plast Surg (Oakv) 23(4):260–264 Prodromidou A et al (2015) Botulinum toxin for the prevention and healing of wound scars: a systematic review of the literature. Plast Surg (Oakv) 23(4):260–264
32.
go back to reference Burns JL, Mancoll JS, Phillips LG (2003) Impairments to wound healing. Clin Plast Surg 30(1):47–56PubMed Burns JL, Mancoll JS, Phillips LG (2003) Impairments to wound healing. Clin Plast Surg 30(1):47–56PubMed
33.
go back to reference Bae DS, Koo DH, Kim JE, Cho JM, Park JO (2020) Effect of botulinum toxin A on scar healing after thyroidectomy: a prospective double-blind randomized controlled trial. J Clin Med 9(3):868PubMedCentral Bae DS, Koo DH, Kim JE, Cho JM, Park JO (2020) Effect of botulinum toxin A on scar healing after thyroidectomy: a prospective double-blind randomized controlled trial. J Clin Med 9(3):868PubMedCentral
34.
go back to reference Bellows S, Jankovic J (2019) Immunogenicity associated with botulinum toxin treatment. Toxins (Basel) 11(9):1–22 Bellows S, Jankovic J (2019) Immunogenicity associated with botulinum toxin treatment. Toxins (Basel) 11(9):1–22
35.
go back to reference Castelão M et al (2017) Botulinum toxin type A therapy for cervical dystonia. Cochrane Database Syst Rev 12(12):cd003633PubMed Castelão M et al (2017) Botulinum toxin type A therapy for cervical dystonia. Cochrane Database Syst Rev 12(12):cd003633PubMed
36.
go back to reference Small R (2014) Botulinum toxin injection for facial wrinkles. Am Fam Physician 90(3):168–175PubMed Small R (2014) Botulinum toxin injection for facial wrinkles. Am Fam Physician 90(3):168–175PubMed
37.
go back to reference Xiao Z, Qu G (2012) Effects of botulinum toxin type a on collagen deposition in hypertrophic scars. Molecules 17(2):2169–2177PubMedPubMedCentral Xiao Z, Qu G (2012) Effects of botulinum toxin type a on collagen deposition in hypertrophic scars. Molecules 17(2):2169–2177PubMedPubMedCentral
38.
go back to reference Suarez E, Syed F, Rasgado TA, Walmsley A, Mandal P, Bayat A (2014) Skin equivalent tensional force alters keloid fibroblast behavior and phenotype. Wound Repair Regen 22(5):557–568PubMed Suarez E, Syed F, Rasgado TA, Walmsley A, Mandal P, Bayat A (2014) Skin equivalent tensional force alters keloid fibroblast behavior and phenotype. Wound Repair Regen 22(5):557–568PubMed
39.
go back to reference Suarez E, Syed F, Alonso-Rasgado T, Mandal P, Bayat A (2013) Up-regulation of tension-related proteins in keloids: knockdown of Hsp27, α2β1-integrin, and PAI-2 shows convincing reduction of extracellular matrix production. Plast Reconstr Surg 131(2):158e–173ePubMed Suarez E, Syed F, Alonso-Rasgado T, Mandal P, Bayat A (2013) Up-regulation of tension-related proteins in keloids: knockdown of Hsp27, α2β1-integrin, and PAI-2 shows convincing reduction of extracellular matrix production. Plast Reconstr Surg 131(2):158e–173ePubMed
41.
go back to reference Lee BJ, Jeong JH, Wang SG, Lee JC, Goh EK, Kim HW (2009) Effect of botulinum toxin type a on a rat surgical wound model. Clin Exp Otorhinolaryngol 2(1):20–27PubMedPubMedCentral Lee BJ, Jeong JH, Wang SG, Lee JC, Goh EK, Kim HW (2009) Effect of botulinum toxin type a on a rat surgical wound model. Clin Exp Otorhinolaryngol 2(1):20–27PubMedPubMedCentral
42.
go back to reference Ortonne JP, Bissett DL (2008) Latest insights into skin hyperpigmentation. J Investig Dermatol Symp Proc 13(1):10–14PubMed Ortonne JP, Bissett DL (2008) Latest insights into skin hyperpigmentation. J Investig Dermatol Symp Proc 13(1):10–14PubMed
43.
go back to reference Vercelli S, Ferriero G, Sartorio F, Stissi V, Franchignoni F (2009) How to assess postsurgical scars: a review of outcome measures. Disabil Rehabil 31(25):2055–2063PubMed Vercelli S, Ferriero G, Sartorio F, Stissi V, Franchignoni F (2009) How to assess postsurgical scars: a review of outcome measures. Disabil Rehabil 31(25):2055–2063PubMed
44.
go back to reference Duncan JAL et al (2006) Visual analogue scale scoring and ranking: a suitable and sensitive method for assessing scar quality? Plast Reconstr Surg 118(4):909–918PubMed Duncan JAL et al (2006) Visual analogue scale scoring and ranking: a suitable and sensitive method for assessing scar quality? Plast Reconstr Surg 118(4):909–918PubMed
45.
go back to reference Bae SH, Bae YC (2014) Analysis of frequency of use of different scar assessment scales based on the scar condition and treatment method. Arch Plast Surg 41(2):111–115PubMedPubMedCentral Bae SH, Bae YC (2014) Analysis of frequency of use of different scar assessment scales based on the scar condition and treatment method. Arch Plast Surg 41(2):111–115PubMedPubMedCentral
46.
go back to reference Nguyen DQ, Potokar T, Price P (2008) A review of current objective and subjective scar assessment tools. J Wound Care 17(3):101–106PubMed Nguyen DQ, Potokar T, Price P (2008) A review of current objective and subjective scar assessment tools. J Wound Care 17(3):101–106PubMed
47.
go back to reference Stavrou D, Haik J, Weissman O, Goldan O, Tessone A, Winkler E (2009) Patient and observer scar assessment scale: how good is it? J Wound Care 18(4):171–176PubMed Stavrou D, Haik J, Weissman O, Goldan O, Tessone A, Winkler E (2009) Patient and observer scar assessment scale: how good is it? J Wound Care 18(4):171–176PubMed
48.
go back to reference Singer AJ, Arora B, Dagum A, Valentine S, Hollander JE (2007) Development and validation of a novel scar evaluation scale. Plast Reconstr Surg 120(7):1892–1897PubMed Singer AJ, Arora B, Dagum A, Valentine S, Hollander JE (2007) Development and validation of a novel scar evaluation scale. Plast Reconstr Surg 120(7):1892–1897PubMed
50.
go back to reference Chen Z et al (2021) The effect of botulinum toxin injection dose on the appearance of surgical scar. Sci Rep 11(1):13670PubMedPubMedCentral Chen Z et al (2021) The effect of botulinum toxin injection dose on the appearance of surgical scar. Sci Rep 11(1):13670PubMedPubMedCentral
51.
go back to reference Gugerell A, Kober J, Schmid M, Buchberger E, Kamola LP, Keck M (2016) Botulinum toxin A: dose-dependent effect on reepithelialization and angiogenesis. Plast Reconstr Surg Glob Open 4(8):e837PubMedPubMedCentral Gugerell A, Kober J, Schmid M, Buchberger E, Kamola LP, Keck M (2016) Botulinum toxin A: dose-dependent effect on reepithelialization and angiogenesis. Plast Reconstr Surg Glob Open 4(8):e837PubMedPubMedCentral
52.
go back to reference Kim YS, Lee HJ, Cho SH, Lee JD, Kim HS (2014) Early postoperative treatment of thyroidectomy scars using botulinum toxin: A split-scar, double-blind randomized controlled trial. Wound Repair Regen 22(5):605–612PubMed Kim YS, Lee HJ, Cho SH, Lee JD, Kim HS (2014) Early postoperative treatment of thyroidectomy scars using botulinum toxin: A split-scar, double-blind randomized controlled trial. Wound Repair Regen 22(5):605–612PubMed
Metadata
Title
A Systematic Review And Meta-Analysis: Botulinum Toxin A Effect on Postoperative Facial Scar Prevention
Authors
Shuai Yue
Mengran Ju
Zhe Su
Publication date
01-02-2022
Publisher
Springer US
Keyword
Botulinum Toxin
Published in
Aesthetic Plastic Surgery / Issue 1/2022
Print ISSN: 0364-216X
Electronic ISSN: 1432-5241
DOI
https://doi.org/10.1007/s00266-021-02596-7

Other articles of this Issue 1/2022

Aesthetic Plastic Surgery 1/2022 Go to the issue